Advertorial: Croma unveils juvenus for skin hydration

18 May 2022

Polynucleotide-based injectable juvenus has the benefits of skin hydration and tissue elasticity restoration for patients.

Distributed by Croma-Pharma, juvenus is an injectable treatment which aims to hydrate the skin, restore tissue elasticity and support fibroblast growth.

juvenus is an elastic, colourless and reabsorbable gel, based on polymerized polynucleotides of natural origin, which has been specially developed for the treatment of various skin concerns of the face and body with instantly visible results.1,2 With a proven safety profile, the juvenus polynucleotide-based gel treatments provides moisturisation and an antioxidative effect which create an optimal environment for fibroblast growth, explains Croma.2,3

Aesthetic practitioner Dr Mayoni Gooneratne explains, “juvenus has proven itself to be the injector’s choice of the next generation of skinboosters and is now being actively asked for by patients. For patients, it sits comfortably between a superficial skin treatment and more invasive injectables like dermal fillers. For practitioners, you can relax and be confident that you will see results that will augment your other offerings. I believe you will not have anything else like this in your portfolio as it sits heads and shoulders above other hyaluronic acid-based skinboosters. Its easy application and minimal downtime makes it appealing for patients along with its fantastic results.”

In the June issue of the Aesthetics journal, Dr Agnieszka Surowiecka will be publishing an article on polynucleotides (PDRN). The next issue will be out on June 7.

For further information on juvenus or training opportunities please contact your local representative here.  

This advertorial was written and supplied by Croma-Pharma. 


Log-in to post a comment